Market Scenario:

Pouchitis is a nonspecific inflammatory condition in the ileal pouch reservoir. The condition exclusively occurs in patients with underlying ulcerative colitis (UC) and is rarely seen in patients with Familial adenomatous polyposis (FAP). Patients with UC or FAP opt for ileal pouch-anal anastomosis (IPAA) surgery as a treatment, and pouchitis appears as an outcome of this surgery in some cases. Pouch endoscopy is usually recommended by the physicians for diagnosis as the procedure yields valuable information on the severity of mucosal inflammation, CD of the pouch or cuffitis, presence or absence of concurrent backwash ileitis, and the presence or absence of structural abnormalities.

However, the side effects of the available treatment options and stringent FDA regulations may hinder the growth of the market over the forecast period. Till now not even a single drug is approved by the FDA for the treatment of pouchitis. However, few are in clinical trials waiting for approval such as Alicaforsen by Atlantic Healthcare plc

The America pouchitis treatment market is expected to grow at a CAGR of 8.34% during the forecast period 2017-2023.

Get Exclusive Sample Report @https://www.marketresearchfuture.com/sample_request/5254

Segmentation:

The America pouchitis treatment market is segmented on the basis of treatment and end user.

On the basis of the treatment, the market is segmented into antibiotics, probiotics, and others. The antibiotic segment is further sub-segmented into ciprofloxacin, metronidazole, rifaximin, and others.

On the basis of the end -users, the market is segmented into hospitals & clinics, research institutes, and others.

Intended Audience:

Hospitals & Clinics
Diagnostic Centers
Research and Development (R&D) Companies
Government Research Institute
Academic Institutes and Universities
Regional Analysis:

On the basis of region, the America pouchitis treatment market is segmented into North America, and South America. North America accounts for a major share owing to the rising cases of pouchitis, and high healthcare expenditure. People in this region are more inclined towards quality healthcare that leads to increase in the healthcare spending. Due to rising prevalence of pouchitis, various companies, private organizations, and government associations are also actively participating to improve the treatment options.

Around 30% of patients with ulcerative colitis (UC) undergo colectomy with ileal pouch-anal anastomosis (IPAA) surgery and up to 50% of patients develop at least one episode of pouchitis. So, rising prevalence of ulcerative colitis is boosting the Americas pouchitis treatment market. According to the Centres for Disease Control and Prevention, in 2015, around 1.3% of the U.S. adults were diagnosed with inflammatory bowel disease (IBD). The prevalence of ulcerative colitis is reported to be 37 to 246 cases per 100,000 individuals whereas, the incidence rate is found to be 2.2 to 14.3 cases per 100,000 person-years.

Key Players:

Some of key the players in the Americas pouchitis treatment market are Pfizer, Abbott, Allergan Plc, Bayer, Takeda Pharmaceutical Company Limited, Alfa sigma, Atlantic Healthcare, Tillotts Pharma AG, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, B. Braun Medical Inc., Valeant Pharmaceuticals, Sucampo Pharmaceuticals, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Synergy Pharmaceuticals, Inc., Ardelyx, Inc., Sebela Pharmaceuticals, Probi, and others

Get Your Customized Report @https://www.marketresearchfuture.com/reports/america-pouchitis-treatment-market-5254

Table of Content:

1  REPORT PROLOGUE

2  MARKET INTRODUCTION

2.1 Definition 11

2.2 Scope Of Study 11

2.3 Research Objective 11

2.4 Assumptions & Limitations 12

2.4.1 Assumptions 12

2.4.2 Limitations 12

2.5 Market Structure 12

3  RESEARCH METHODOLOG

3.1.1 Primary Research Methodology 14

3.1.2 Data Points Received From The Doctors/ Gastrologist: 14

3.1.3 Data Points Received From The Manufacturer/ Pharmaceutical Companies: 14

3.1.4 Data Points Received From Hospitals, Clinics: 15

3.1.5 Secondary Research Methodology 16

3.1.6 Market Share Analysis 19

3.1.7 Trade Analysis 19

3.1.8 Market Pricing Approach 19

TOC Continued…!

Get Discount @https://www.marketresearchfuture.com/check-discount/5254

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]